Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Vera Therapeutics Inc (NASDAQ: VERA) was $40.01 for the day, down -2.03% from the previous closing price of $40.84. In other words, the price has decreased by -$2.03 from its previous closing price. On the day, 0.73 million shares were traded. VERA stock price reached its highest trading level at $43.43 during the session, while it also had its lowest trading level at $39.98.
Ratios:
Our analysis of VERA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 21.15 and its Current Ratio is at 21.15. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on January 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.
On December 18, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on December 18, 2023, with a $29 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 25 ’24 when Fordyce Marshall sold 23,125 shares for $46.05 per share. The transaction valued at 1,064,809 led to the insider holds 307,972 shares of the business.
MARSHALL FORDYCE bought 7,500 shares of VERA for $350,325 on Sep 25 ’24. On Sep 19 ’24, another insider, SEIDENBERG BETH C, who serves as the Director of the company, sold 13,823 shares for $42.31 each. As a result, the insider received 584,793 and left with 146,553 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 2239719680 and an Enterprise Value of 1862101888.
Stock Price History:
Over the past 52 weeks, VERA has reached a high of $50.78, while it has fallen to a 52-week low of $9.24. The 50-Day Moving Average of the stock is 2.53%, while the 200-Day Moving Average is calculated to be 8.24%.
Shares Statistics:
VERA traded an average of 537.22K shares per day over the past three months and 757170 shares per day over the past ten days. A total of 44.45M shares are outstanding, with a floating share count of 41.54M. Insiders hold about 24.24% of the company’s shares, while institutions hold 90.12% stake in the company. Shares short for VERA as of 1726185600 were 6460497 with a Short Ratio of 12.03, compared to 1723680000 on 6082990. Therefore, it implies a Short% of Shares Outstanding of 6460497 and a Short% of Float of 16.580000000000002.
